会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • Method and device for determining the transmembrane pressure in an extracorporeal blood treatment
    • 用于确定体外血液处理中跨膜压力的方法和装置
    • US08676512B2
    • 2014-03-18
    • US12809791
    • 2008-12-17
    • Klaus BalschatAlfred GagelMichael KulzReiner Spickermann
    • Klaus BalschatAlfred GagelMichael KulzReiner Spickermann
    • A61M1/34G06F19/00G06F17/40
    • A61M1/16A61M1/1601A61M1/34A61M1/3403A61M1/341A61M1/3413A61M1/36A61M2205/3331A61M2205/3334A61M2205/50
    • A method and device are provided for determining the transmembrane pressure during an extracorporeal blood treatment in which blood flows at a defined blood flow rate through an arterial blood conduit of an extracorporeal blood circuit into the inlet of a first chamber of a dialyzer, which is divided by a semipermeable membrane into the first chamber and a second chamber, and flows through a venous blood conduit from the outlet of the first chamber of the dialyzer, while dialysis liquid flows through a dialysis liquid supply conduit into the inlet of the second chamber of the dialyzer and flows through a dialaysis liquid discharge conduit from the outlet of the second chamber of the dialyzer. The method and the device for determining the transmembrane pressure are such that the pressure on the blood side and on the dialysis liquid side of the dialyzer is measured with relatively little technical outlay, specifically with fewer than four pressure sensors, and a preliminary uncorrected value is calculated for the transmembrane pressure and is thereafter corrected by a correction variable that is dependent on a variable correlating with the viscosity of the blood.
    • 提供了一种用于在体外血液处理期间确定跨膜压力的方法和装置,其中血液以限定的血液流量通过体外血液回路的动脉血管流入到透析器的第一腔室的入口中,该第一腔室被分开 通过半透膜进入第一腔室和第二腔室,并且从透析器的第一腔室的出口流过静脉血液导管,同时透析液体流过透析液体供应管道进入第二腔室的入口 透析器,并从透析器的第二腔室的出口流过拨号液体排出导管。 用于确定跨膜压力的方法和装置使得透析器的血液侧和透析液体侧的压力以相对较少的技术支出来测量,特别是使用少于四个的压力传感器,初步未校正的值是 计算跨膜压力,然后通过依赖于与血液粘度相关的变量的校正变量进行校正。
    • 16. 发明授权
    • Method and device for extracorporeal blood treatment with a means for continuous monitoring of the extracorporeal blood treatment
    • 用于体外血液处理的方法和装置,用于持续监测体外血液治疗的手段
    • US06736789B1
    • 2004-05-18
    • US09176744
    • 1998-10-21
    • Reiner Spickermann
    • Reiner Spickermann
    • A61M3700
    • A61B5/02125A61B5/0285A61M1/3413A61M1/3639A61M2230/30Y10S128/03A61M2230/005
    • A method and a device for continuous, noninvasive monitoring of an extracorporeal blood treatment, a patient's blood pressure or a quantity that correlates with the blood pressure is measured and compared with a predetermined limit value. If the measured blood pressure or its relative change drops below the predetermined limit value, an activation or deactivation signal is generated to initiate an intervention in the treatment sequence. The blood treatment machine therefore has a control unit. The continuous, noninvasive measurement of blood pressure is based on a determination of the propagation rate or transit time of the pulse waves produced by the patient's cardiac contractions and their propagation through the arterial system. To determine the pulse wave velocity or transit time, the blood treatment machine has an electrocardiograph and a device for detecting the pulse waves at a location on the patient remote from the heart.
    • 对体外血液处理,患者血压或与血压相关的量进行连续无创监测的方法和装置,并与预定的极限值进行比较。 如果测量的血压或其相对变化降低到预定极限值以下,则产生激活或去激活信号以启动治疗序列中的干预。 因此,血液处理机具有控制单元。 连续无创的血压测量是基于由患者心脏收缩产生的脉搏波及其通过动脉系统传播的脉搏波的传播速率或传播时间的确定。 为了确定脉搏波速度或通过时间,血液处理机具有心电图仪和用于检测远离心脏的患者位置处的脉搏波的装置。